Suven Life Sciences Ltd
NSE:SUVEN

Watchlist Manager
Suven Life Sciences Ltd Logo
Suven Life Sciences Ltd
NSE:SUVEN
Watchlist
Price: 125 INR 0.68%
Market Cap: 27.3B INR
Have any thoughts about
Suven Life Sciences Ltd?
Write Note

Suven Life Sciences Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Suven Life Sciences Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
DIVISLAB
DCAL
WINDLAS
SYNGENE
I
INNOVACAP

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Suven Life Sciences Ltd
NSE:SUVEN
Cash & Cash Equivalents
â‚ą1.6B
CAGR 3-Years
52%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Cash & Cash Equivalents
â‚ą3.4B
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Cash & Cash Equivalents
â‚ą4.1B
CAGR 3-Years
14%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Windlas Biotech Ltd
NSE:WINDLAS
Cash & Cash Equivalents
â‚ą309.5m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Cash & Cash Equivalents
â‚ą857m
CAGR 3-Years
-49%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Cash & Cash Equivalents
â‚ą117.3m
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Suven Life Sciences Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.6B INR

Based on the financial report for Jun 30, 2024, Suven Life Sciences Ltd's Cash & Cash Equivalents amounts to 1.6B INR.

What is Suven Life Sciences Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-7%

Over the last year, the Cash & Cash Equivalents growth was 11%. The average annual Cash & Cash Equivalents growth rates for Suven Life Sciences Ltd have been 52% over the past three years , -7% over the past five years .

Back to Top